Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03886753 · ClinicalTrials.gov registry record
Pharmacokinetic (PK) and Pharmacodynamics (PD) Study of Ilera Specific Products
A clinical trial, sponsored by Children's Hospital of Philadelphia.
- Terminated
- Registry status
- 10
- Enrollment target
NCT03886753 is a clinical trial that was terminated before completion, run by Children's Hospital of Philadelphia. The registered enrollment target is 10 participants.
The verdict
NCT03886753 was terminated before completion, sponsored by Children's Hospital of Philadelphia.
- TERMINATED
- Registry status
- 10 participants
- Enrollment target
Study Summary
This is an observational study of medical marijuana manufactured and dispensed by Ilera and given as standard treatment for a variety of approved serious medical conditions as defined by individual state law. All patients who are receiving one of the four formulations (Dream, Soothe, Shine and Ease) of medical marijuana will be provided a study flyer and asked to contact the study team via phone or email. Once the study team confirms eligibility, the study team will meet the subject face-to-face most likely at their dispensary (or other mutually agreeable location) and obtain informed consent, and assent when appropriate. Initial baseline demographic information, medical history and medication inventory will be completed. Also, since it is possible that the Investigators will enroll subjects across the region, Investigators anticipate the need to seek consent over the phone for many patients. This will be done via Skype, Go to Meeting, Facetime or similar platforms so that the Investigators can have a face to face interaction with the potential subjects. Regardless of where this discussion takes place (i.e., in person or via the web), all reasonable safeguards to ensure patient privacy will be taken. Patients or their legally authorized representative (LAR) will be given sufficient (i.e., up to several hours/days) to make a decision to participate in this study. Study staff will fax or email the consent form for their signature and no study procedures will begin until the signed consent form is received by the study team. The subjects or their LARs will be instructed on obtaining the blood samples. Blood draws will be completed in the subjects' home after one of their standard doses is taken.
Interventions
- OTHER Registry
- OTHER PK microsampling of blood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2019-05-15 |
| Est. Completion | 2020-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03886753
The ClinicalTrials.gov registry entry for NCT03886753 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Registry is the first listed.
NCT03886753 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03886753 about?
NCT03886753 is a clinical study titled "Pharmacokinetic (PK) and Pharmacodynamics (PD) Study of Ilera Specific Products". This is an observational study of medical marijuana manufactured and dispensed by Ilera and given as standard treatment for a variety of approved serious medical conditions as defined by individual state law. All patients who are receiving one of the four formulations (Dream, Soothe, Shine and Ease)...
What is the current status of trial NCT03886753?
This trial is currently terminated. The enrollment target is 10 participants. The study started on 2019-05-15. Estimated completion is 2020-06-30.
What interventions are being tested in trial NCT03886753?
The interventions under investigation include: Registry (OTHER), PK microsampling of blood (OTHER).
Who is sponsoring clinical trial NCT03886753?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.